Jupiter Neurosciences
JUNS
12 hedge funds and large institutions have $1.64M invested in Jupiter Neurosciences in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
33% more funds holding
Funds holding: 9 → 12 (+3)
0.03% less ownership
Funds ownership: 0.05% → 0.02% (-0.03%)
31% less capital invested
Capital invested by funds: $2.39M → $1.64M (-$752K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YAG
Yorkville Advisors Global
Mountainside,
New Jersey
|
+$175K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44K |
| 3 |
ACG
Allen Capital Group
Grand Island,
Nebraska
|
+$39.9K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$38.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vestor Capital
Chicago,
Illinois
|
-$1.29M |
| 2 |
Citigroup
New York
|
-$21.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7.2K |
JUNS Hedge Fund Activity: Q4 2025 in Review
12 institutional investors reported a position in Jupiter Neurosciences (JUNS) for Q4 2025, worth a combined $1.64M — down 31% from $2.39M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new JUNS positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Yorkville Advisors Global, opening a new position worth an estimated $175K. The largest seller was Vestor Capital, cutting an estimated $1.29M.
- 12 institutional investors held Jupiter Neurosciences (JUNS) as of Q4 2025, up from 9 in Q3 2025.
- Funds reported $1.64M of Jupiter Neurosciences stock for Q4 2025, down 31% quarter-over-quarter.
- 5 funds opened new Jupiter Neurosciences positions in Q4 2025 and 2 closed out, a net change of +3 holders.
- The largest Jupiter Neurosciences buyer in Q4 2025 was Yorkville Advisors Global, an estimated $175K added.
- The largest Jupiter Neurosciences seller in Q4 2025 was Vestor Capital, an estimated $1.29M sold.
Based on aggregated 13F filings for Q4 2025.